Archivos suplementarios
Palabras clave
Inmunodeficiencia común variable
Inmunodeficiencia primaria
Resumen
La inmunodeficiencia común variable (IDCV) es la inmunodeficiencia primaria sintomática más prevalente: se estima un caso entre 10 000 a 50 000 habitantes. Esta enfermedad heterogénea se caracteriza por disminución de las inmunoglobulinas séricas, una producción deficiente de anticuerpos específicos tras la vacunación y por infecciones bacterianas recurrentes, en particular de los tractos respiratorio y gastrointestinal. Un subgrupo de pacientes se caracteriza por manifestaciones adicionales, a menudo predominantes, de desregulación inmunitaria en lugar de inmunodeficiencia pura. Aproximadamente, 30 % de los pacientes con IDCV desarrolla autoinmunidad. La mitad de las complicaciones se puede atribuir a citopenia autoinmunitaria, pero también a otros tipos de autoinmunidad tales como enfermedades autoinmunitarias específicas de órganos, que se manifiestan a menudo como enfermedad inflamatoria: enfermedad inflamatoria intestinal, enfermedad celiaca, enfermedad pulmonar intersticial, algunas formas de artritis, vitíligo y muchas otras. Nuevos defectos monogénicos aclaran el mecanismo inmunopatológico que provoca la coincidencia de inmunodeficiencia y autoinmunidad. Las enfermedades autoinmunitarias se han convertido en el principal desafío clínico en la IDCV, con nuevas herramientas de diagnóstico, especialmente genéticas, que mejoran la comprensión de las formas variantes de desregulación inmunitaria.
Referencias
Janeway CA, Apt L, Glitin D. Agammaglobulinemia. Trans Assoc Am Physicians. 1953;66:200-202.
Cunningham-Rundles C, Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol. 1999;92(1):34-48. DOI: 10.1006/clim.1999.4725
Salzer U, Warnatz K, Peter HH. Common variable immunodeficiency - an update. Arthritis Res Ther. 2012;14(5):1-11. DOI: 10.1186/ar4032
Patuzzo G, Barbieri A, Tinazzi E, Veneri D, Argentino G, Moretta F, et al. Autoimmunity and infection in common variable immunodeficiency (CVID). Autoimmun Rev. 2016;15(9):877-882. DOI: 10.1016/j.autrev.2016.07.011
Horn J, Thon V, Bartonkova D, Salzer U, Warnatz K, Schlesier M, et al. Anti-IgA antibodies in common variable immunodeficiency (CVID): diagnostic workup and therapeutic strategy. Clin Immunol. 2007;122:156-162. DOI: 10.1016/j.clim.2006.10.002
Park MA, Li JT, Hagan JB, Maddox DE, Abraham RS. Common variable immunodeficiency: a new look at an old disease. Lancet. 2008;372(9637):95616. DOI: 10.1016/S0140-6736(08)61199-X
Yong PFK, Thaventhiran JED, Grimbacher B. “A rose is a rose is a rose,” but CVID is not CVID. Common variable immune deficiency (CVID), what do we know in 2011? Adv Immunol. 2011;111:47-107. DOI: 10.1016/B978-0-12-385991-4.00002-7
Di Renzo M, Pasqui AL, Auteri A. Common variable immunodeficiency: a review. Clin Exp Med. 2004;3(4):211-217. DOI: 10.1007/s10238-004-0027-2
Bonilla FA, Bernstein IL, Khan DA, Ballas ZK, Chinen J, Frank MM, et al. Practice parameter for the diagnosis and management of primary immunodeficiency. Ann Allergy, Asthma Immunol. 2005;94(5 Suppl 1):S1-S63. DOI: 10.1016/S1081-1206(10)61142-8
Hammarström L, Vorechovsky I, Webster D. Selective IgA deficiency (SIgAD) and common variable immunodeficiency (CVID). Clin Exp Immunol. 2000;120(2):225-231. DOI: 10.1046/j.1365-2249.2000.01131.x
Morimoto Y, Routes JM. Immunodeficiency overview. Prim Care. 2008;35(1):159-173. DOI: 10.1016/j.pop.2007.09.004
Mehra A, Sidi P, Doucette J, Estrella L, Rouvelas H, Cunningham-Rundles C. Subspecialty evaluation of chronically ill hospitalized patients with suspected immune defects. Ann Allergy, Asthma Immunol. 2007;99(2):143-150. DOI: 10.1016/S1081-1206(10)60638-2
Eades-Perner AM, Gathmann B, Knerr V, Guzman D, Veit D, Kindle G, et al. The European internet-based patient and research database for primary immunodeficiencies: results 2004-06. Clin Exp Immunol. 2007;147(2):306-312. DOI: 10.1111/j.1365-2249.2006.03292.x
Deane S, Selmi C, Naguwa SM, Teuber SS, Gershwin ME. Common variable immunodeficiency: etiological and treatment issues. Int Arch Allergy Immunol. 2009;150(4):311-324. DOI: 10.1159/000226232
Agarwal S, Cunningham-Rundles C. Assessment and clinical interpretation of reduced IgG values. Ann Allergy Asthma Immunol. 2007;99(3):281-283. DOI: 10.1016/S1081-1206(10)60665-5
Conley ME. Diagnostic guidelines - An international consensus document. Clin Immunol. 1999;93(3):189. DOI: 10.1006/clim.1999.4798
Chapel H, Lucas M, Lee M, Bjorkander J, Webster D, Grimbacher B, et al. Common variable immunodeficiency disorders: division into distinct clinical phenotypes. Blood. 2008;112(2):277-286. DOI: 10.1182/blood-2007-11-124545
Gomes-Ochtrop ML, Goldacker S, May AM, Rizzi M, Draeger R, Hauschke D, et al. T and B lymphocyte abnormalities in bone marrow biopsies of common variable immunodeficiency. Blood. 2016;118(2):309-318. DOI: 10.1182/blood-2010-11-321695
Taubenheim N, von Hornung M, Durandy A, Warnatz K, Corcoran L, Peter H, et al. Defined blocks in terminal plasma cell differention of common variable immunodeficiency patients. J Immunol. 2005;175(8):5498-5503. DOI: 10.4049/jimmunol.175.8.5498
Agematsu K, Fututani T, Hokibara S, Kobayashi M, Takamoto M, Tsukada S, et al. Absence of memory B cells in patients with common variable immunodeficiency. Clin Immunol. 2002;103(1):34-42. DOI: 10.1006/clim.2001.5197
Piqueras B, Lavenu-Bobbled C, Galicier L, Bergeron-van der Cruyssen F, Mouthon L, Chevret S, et al. Common variable immunodeficiency patient classification based on impaired B cell memory differentiation correlates with clinical aspects. J Clin Immunol. 2003;23(5):385-400. DOI: 10.1023/a:1025373601374
Warnatz K, Denz A, Dräger R, Braun M, Groth C, Wolff-Vorbeck G, et al. Severe deficiency of switched memory B cells (CD27+IgM-IgD-) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease. Blood. 2002;99(5):1544-1551. DOI: 10.1182/blood.v99.5.1544
Agarwal S, Cunningham-Rundles C. Autoimmunity in common variable immunodeficiency. Ann Allergy Asthma Immunol. 2019;123(5):454-460. DOI: 10.1016/j.anai.2019.07.014
Warnatz K, Voll RE. Pathogenesis of autoimmunity in common variable immunodeficiency. Front Immunol. 2012;3:210. DOI: 10.3389/fimmu.2012.00210
Feuille EJ, Anooshiravani N, Sullivan KE, Fuleihan RL, Cunningham-Rundles C. Autoimmune cytopenias and associated conditions in CVID: a report From the USIDNET registry. J Clin Immunol. 2018;38(1):28-34. DOI: 10.1007/s10875-017-0456-9
Resnick ES, Moshier EL, Godbold JH, Cunningham-Rundles C. Morbidity and mortality in common variable immune deficiency over 4 decades. Blood. 2016;119(7):1650-1657. DOI: 10.1182/blood-2011-09-377945
Wang J, Cunningham-Rundles C. Treatment and outcome of autoimmune hematologic disease in common variable immunodeficiency (CVID). J Autoimmun. 2005;25(1):57-62. DOI: 10.1016/j.jaut.2005.04.006
Guffroy A, Mourot-Cottet R, Gérard L, Gies V, Lagresle C, Pouliet A, et al. Neutropenia in patients with common variable immunodeficiency: a rare event associated with severe outcome. J Clin Immunol. 2017;37(7):715-726. DOI: 10.1007/s10875-017-0434-2
Gutiérrez MJ, Sullivan KE, Fuleihan R, Bingham CO. Phenotypic characterization of patients with rheumatologic manifestations of common variable immunodeficiency. Semin Arthritis Rheum. 2018;48(2):318-326. DOI: 10.1016/j.semarthrit.2018.02.013
Abolhassani H, Amirkashani D, Parvaneh N, Mohammadinejad P, Gharib B, Shahinpour S, et al. Autoimmune phenotype in patients with common variable immunodeficiency. J Investig Allergol Clin Immunol. 2013;23(5):323-329.
Ramírez-Vargas N, Arablin-Oropeza SE, Mojica-Martínez D, Yamazaki-Nakashimada MA, de la Luz-García-Cruz M, Terán-Juárez LM, et al. Clinical and immunological features of common variable immunodeficiency in Mexican patients. Allergol Immunopathol (Madr). 2014;42(3):235-240. DOI: 10.1016/j.aller.2013.01.007
Maglione PJ. Autoimmune and lymphoproliferative complications of common variable immunodeficiency. Curr Allergy Asthma Rep. 2016;16(3):1-10. DOI: 10.1007/s11882-016-0597-6
Rao DA, Gurish MF, Marshall JL, Slowikowski K, Fonseka CY, Liu Y, et al. Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis. Nature. 2017;542(7639):110-114. DOI: 10.1038/nature20810
Maglione PJ, Overbey JR, Cunningham-Rundles C. Progression of CVID interstitial lung disease accompanies distinct pulmonary and laboratory findings. J Allergy Clin Immunol Pract. 2015;3(6):941-950. DOI: 10.1016/j.jaip.2015.07.004
Ayubi E, Safiri S. Predictors of granulomatous lymphocytic interstitial lung disease in common variable immunodeficiency: methodological issues. Ann Allergy, Asthma Immunol. 2017;119(3):296. DOI: 10.1016/j.anai.2017.06.005
Maglione PJ, Ko HM, Beasley MB, Strauchen JA, Cunningham-Rundles C. Tertiary lymphoid neogenesis is a component of pulmonary lymphoid hyperplasia in patients with common variable immunodeficiency. J Allergy Clin Immunol. 2014;133(2):535-542. DOI: 10.1016/j.jaci.2013.08.022
Picard C, Bobby-Gaspar H, Al-Herz W, Bousfiha A, Casanova JL, Chatila T, et al. International Union of Immunological Societies: 2017 Primary Immunodeficiency Diseases Committee Report on Inborn Errors of Immunity. J Clin Immunol. 2018;38(1):96-128. DOI: 10.1007/s10875-017-0464-9
Gathmann B, Mahlaoui N, Gérard L, Oksenhendler E, Warnatz K, Schulze I, et al. Clinical picture and treatment of 2212 patients with common variable immunodeficiency. J Allergy Clin Immunol. 2014;134(1):7-9. DOI: 10.1016/j.jaci.2013.12.1077
Daniels JA, Lederman HM, Maitra A, Montgomery EA. Gastrointestinal tract pathology in patients with common variable immunodeficiency (CVID): a clinicopathologic study and review. Am J Surg Pathol. 2007;31(12):1800-1812. DOI: 10.1097/PAS.0b013e3180cab60c
Agarwal S, Smereka P, Harpaz N, Cunningham-Rundles C, Mayer L. Characterization of immunologic defects in patients with common variable immunodeficiency (CVID) with intestinal disease. Inflamm Bowel Dis. 2011;17(1):251-259. DOI: 10.1002/ibd.21376
Megna M, Pecoraro A, Balato N, Villani A, Crescenzi L, Balato A, et al. Psoriasis in a cohort of patients with common variable immunodeficiency. Br J Dermatol. 2019;180(4):935-936. DOI: 10.1111/bjd.17408
Plana Pla A, Bassas-Vila J, Roure S, Ferrándiz C. Necrotizing and sarcoidal granulomas in the skin and synovial membrane, associated with common variable immunodeficiency. Clin Exp Dermatol. 2015;40(4):379-382. DOI: 10.1111/ced.12543
Pollock G, Sharma A, Minuk GY. Autoimmune hepatitis in a patient with common variable immunodeficiency. ACG Case Reports J. 2020;7(11):e00467. DOI: 10.14309/crj.0000000000000467
Liston A, Enders A, Siggs OM. Unravelling the association of partial T-cell immunodeficiency and immune dysregulation. Nat Rev Immunol. 2008;8(7):545-558. DOI: 10.1038/nri2336
van de Ven AAJM, Warnatz K. The autoimmune conundrum in common variable immunodeficiency disorders. Curr Opin Allergy Clin Immunol. 2015;15(6):514-524. DOI: 10.1097/ACI.0000000000000218
Fisher GH, Rosenberg FJ, Straus SE, Dale JK, Middelton LA, Lin AY, et al. Dominant interfering fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell. 1995;81(6):935-946. DOI: 10.1016/0092-8674(95)90013-6
Sakaguchi S, Miyara M, Costantino CM, Hafler DA. FOXP3 + regulatory T cells in the human immune system. Nat Rev Immunol. 2010;10(7):490-500. DOI: 10.1038/nri2785
Rosser EC, Mauri C. Regulatory B cells: origin, phenotype, and function. Immunity. 2015;42(4):607-612. DOI: 10.1016/j.immuni.2015.04.005
Bennett CL, Christie J, Ramsdell F, Brunkow ME, Ferguson PJ, Whitesell L, et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet. 2001;27(1):20-21. DOI: 10.1038/83713
Arumugakani G, Wood PMD, Carter CRD. Frequency of treg cells is reduced in CVID patients with autoimmunity and splenomegaly and is associated with expanded CD21lo B lymphocytes. J Clin Immunol. 2010;30(2):292-300. DOI: 10.1007/s10875-009-9351-3
López-Herrera G, Segura-Méndez N, O’Farril-Romanillos P, Núñez-Núñez M, Zárate-Hernández M, Mogica-Martínez D, et al. Low percentages of regulatory T cells in common variable immunodeficiency (CVID) patients with autoimmune diseases and its association with increased numbers of CD4 + CD45RO + T and CD21 low B cells. Allergol Immunopathol (Madr). 2019;47(5):457-466. DOI: 10.1016/j.aller.2019.01.003
Schubert D, Bode C, Kenefeck R, Hou TZ, Wing JB, Kennedy A, et al. Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations. Nat Med. 2014;20(12):1410-1416. DOI: 10.1038/nm.3746
Lopez-Herrera G, Tampella G, Pan-Hammarstro Q, Trujillo-Vargas CM, Phadwal K, Simon AK, et al. Deleterious mutations in LRBA are associated with a syndrome of immune deficiency and autoimmunity. Am J Hum Genet. 2012;90:986-1001. DOI: 10.1016/j.ajhg.2012.04.015
Lo B, Zhang K, Lu W, Zheng L, Zhang Q, Kanellopoulou C, et al. Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy. Science. 2015;349(6246):436-440. DOI: 10.1126/science.aaa1663
Aspalter RM, Eibl MM, Wolf HM. Defective T-cell activation caused by impairment of the TNF receptor 2 costimulatory pathway in common variable immunodeficiency. J Allergy Clin Immunol. 2007;120(5):1193-200. DOI: 10.1016/j.jaci.2007.07.004
van Zelm MC, Reisli I, van der Burg M, van Noesel CJM, van Tol MJD, Woellner C, et al. An antibody-deficiency syndrome due to mutations in the CD19 gene. N Engl J Med. 2006;354(18):1901-1912. DOI: 10.1056/NEJMoa051568
van Zelm MC, van Dongen JJM, van der Burg M, Smet J, Adams B, Mascart F, et al. CD81 gene defect in humans disrupts CD19 complex formation and leads to antibody deficiency. J Clin Invest. 2010;120(4):1265-1274. DOI: 10.1172/JCI39748
Angulo I, Vadas O, Garçon F, Banham-Hall E, Plagnol V, Leahy TR, et al. Phosphoinositide 3-kinase δ gene mutation predisposes to respiratory infection and airway damage. Science. 2013;342(6160):866-871. DOI: 10.1126/science.1243292
Deau M-C, Heurtier L, Frange P, Suarez F, Bole-Feysot C, Nitschke P, et al. A human immunodeficiency caused by mutations in the PIK3R1 gene. J Clin Invest. 2014;124(9):3923-3928. DOI: 10.1172/JCI75746
Fliegauf M, Bryant VL, Frede N, Slade C, Woon ST, Lehnert K, et al. Haploinsufficiency of the NF-κB1 subunit p50 in common variable immunodeficiency. Am J Hum Genet. 2015;97(3):389-403. DOI: 10.1016/j.ajhg.2015.07.008
Lindsley AW, Qian Y, Valencia CA, Shah K, Zhang K, Assa’ad A. Combined immune deficiency in a patient with a novel NFKB2 mutation. J Clin Immunol. 2014;34(8):910-915. DOI: 10.1007/s10875-014-0095-3
Grimbacher B, Hutloff A, Schlesier M, Glocker E, Warnatz K, Dräger R, et al. Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency. Nat Immunol. 2003;4(3):261-268. DOI: 10.1038/ni902
Bogaert JA, Dullaers M, Lambrecht BN, Vermaelen KY, de Baere E, Haerynck F. Genes associated with common variable immunode fi ciency : one diagnosis to rule them all ? J Med Genet. 2016;53(9):575-590. DOI: 10.1136/jmedgenet-2015-103690
Ombrello MJ, Remmers EF, Sun G, Freeman AF, Datta S, Torabi-Parizi P, et al. Cold urticaria, immunodeficiency, and autoimmunity related to PLCG2 deletions. N Engl J Med. 2012;366(4):330-338. DOI: 10.1056/NEJMoa1102140
Belot A, Kasher PR, Trotter EW, Foray AP, Debaud AL, Rice GI, et al. Protein kinase Cδ deficiency causes mendelian systemic lupus erythematosus with B cell-defective apoptosis and hyperproliferation. Arthritis Rheum. 2013;65(8):2161-2171. DOI: 10.1002/art.38008
Uzel G, Sampaio EP, Lawrence MG, Hsu AP, Hackett M, Dorsey MJ, et al. Dominant gain-of-function STAT1 mutations in FOXP3 wild-type immune dysregulation-polyendocrinopathy-enteropathy-X-linked-like syndrome. J Allergy Clin Immunol. 2013;131(6):1611-1623. DOI: 10.1016/j.jaci.2012.11.054
Milner JD, Vogel TP, Forbes L, Ma CA, Stray-Pedersen A, Niemela JE, et al. Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations. Blood. 2015;125(4):591-599. DOI: 10.1182/blood-2014-09-602763
Romberg N, Chamberlain N, Saadoun D, Gentile M, Kinnunen T, Ng YS, et al. CVID-associated TACI mutations affect autoreactive B cell selection and activation. J Clin Invest. 2013;123(10):4283-4293. DOI: 10.1172/JCI69854
Warnatz K, Salzer U, Rizzi M, Fischer B, Gutenberger S, Bo J, et al. B-cell activating factor receptor deficiency is associated with an adult-onset antibody deficiency syndrome in humans. Proc Natl Acad Sci U S A. 2009;106(33):13945-13950. DOI: 10.1073/pnas.0903543106
Gereige JD, Maglione PJ. Current understanding and recent developments in common variable immunodeficiency associated autoimmunity. Front Immunol. 2019;10:2753. DOI: 10.3389/fimmu.2019.02753
Michel M, Chanet V, Galicier L, Ruivard M, Levy Y, Hermine O, et al. Autoimmune thrombocytopenic purpura and common variable immunodeficiency: analysis of 21 cases and review of the literature. Medicine (Baltimore). 2004;83(4):254-263. DOI: 10.1097/01.md.0000133624.65946.40
Gobert D, Bussel JB, Cunningham-Rundles C, Galicier L, Dechartres A, Berezne A, et al. Efficacy and safety of rituximab in common variable immunodeficiency-associated immune cytopenias: a retrospective multicentre study on 33 patients. Br J Haematol. 2011;155(4):498-508. DOI: 10.1111/j.1365-2141.2011.08880.x
Kano G, Nakatani T, Yagi K, Sakamoto I, Imamura T. Complicated pathophysiology behind rituximab-induced persistent hypogammaglobulinemia. Immunol Lett. 2014;159(1-2):76-78. DOI: 10.1016/j.imlet.2013.10.005
Carrabba M, Barcellini W, Fabio G. Use of thrombopoietin-receptor agonist in CVID-associated immune thrombocytopenia. J Clin Immunol. 2016;36(5):434-436. DOI: 10.1007/s10875-016-0282-5
Bates CA, Ellison MC, Lynch DA, Cool CD, Brown KK, Routes JM. Granulomatous-lymphocytic lung disease shortens survival in common variable immunodeficiency. J Allergy Clin Immunol. 2004;114(2):415-421. DOI: 10.1016/j.jaci.2004.05.057
Uzel G, Karanovic D, Su H, Rump A, Agharahimi A, Holland SM, et al. Management of cytopenias in CTLA4 haploinsufficiency using abatacept and sirolimus. Blood. 2018;132(1):2409. DOI: 10.1182/blood-2018-99-120185
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial 4.0.
Derechos de autor 2021 Revista Alergia México